Mydecine Innovations Group Inc. (CSE: MYCO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0100
0.00 (0.00%)
Jan 20, 2025, 1:38 PM EST
-50.00%
Market Cap 441.27K
Revenue (ttm) n/a
Net Income (ttm) -12.46M
Shares Out n/a
EPS (ttm) -0.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 107,940
Average Volume 100,489
Open 0.0100
Previous Close 0.0100
Day's Range 0.0050 - 0.0100
52-Week Range 0.0050 - 0.0250
Beta 2.78
RSI 52.74
Earnings Date Mar 31, 2025

About CSE: MYCO

Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. Its lead product drug candidates include MYCO-005. The company also develops MYCO-006 and MYCO-007. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entacto... [Read more]

Sector Healthcare
Founded 2013
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol MYCO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.